Log In
BCIQ
Print this Print this
 

Vitaros, alprostadil

Also known as: Befar (formerly Alprox-TD)

  Manage Alerts
Collapse Summary General Information
Company Apricus Biosciences Inc.
DescriptionTopical prostaglandin E1 (PGE1) cream formulated with the company's NexACT transdermal delivery technology
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationErectile dysfunction (ED)
Indication DetailsTreat erectile dysfunction (ED)
Regulatory Designation
PartnerAbbVie Inc.;
Bracco S.p.A.;
Elis Pharmaceuticals Ltd.;
Ferring Pharmaceuticals A/S;
Global Harvest Pharma;
Laboratoires Majorelle;
Neopharm Group;
Recordati S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

10

$185.6M

$11.5M

$110.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today